Nasdaq · Healthcare

ESTABLISHMENT LABS HOLDINGS INC. (ESTA)

As-reported financials and recent SEC filings for ESTABLISHMENT LABS HOLDINGS INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.

Snapshot

Revenue

$211.1M

Net income

$-51.1M

Net margin

-24.2%

Diluted EPS

$-1.72

ROE

-216.9%

P/E (TTM)

—

Market cap

—

Debt / equity

10.5×

Income statement (as reported)

Line	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$211.1M	$166.0M	$165.2M	$161.7M	$126.7M
Gross profit	$146.3M	$109.5M	$107.0M	$106.6M	$85.4M
Operating income	$-39.0M	$-50.0M	$-65.0M	$-39.7M	$-25.1M
Net income	$-51.1M	$-84.6M	$-78.5M	$-75.2M	$-41.1M
Diluted EPS	$-1.72	$-3.00	$-3.07	$-3.08	$-1.72

Source: company XBRL financial statements on SEC EDGAR.

Recent SEC filings

42026-07-01

42026-07-01

42026-07-01

4/A2026-07-01

42026-07-01

42026-07-01

42026-06-29

32026-06-29

Largest Healthcare peers

UNH

UNITEDHEALTH GROUP INC

All Healthcare companies →

Go deeper on ESTA

Search ESTABLISHMENT LABS HOLDINGS INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.

Start free

Or check your whole portfolio free — no account needed.

Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.